Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 33-40

  Kruijshoop, Margriet ^a   Feskens, Edith J M ^b   Blaak, Ellen E ^c   De Bruin, Tjerk W A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cost effectiveness; Diabetes epidemiology; Diabetes screening; Glucose tolerance; Insulin resistance; Prevention

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; VALIDATION PROCESS; VENOUS BLOOD; WORLD HEALTH ORGANIZATION;

EID: 1142279539     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.033     Document Type: Article

References (29)

1. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. WHO Technical Report Series. 1999;1-59.
2. Solnica B., Naskalski J.W., Sieradzki J. Analytical performance of glucometers used for routine glucose self-monitoring of diabetic patients. Clin. Chim. Acta. 331:2003;29-35.
3. Rheney C.C., Kirk J.K. Performance of three blood glucose meters. Ann. Pharmacother. 34(3):2000;317-321.
4. Larsson-Cohn U. Differences between capillary and venous blood glucose during oral glucose tolerance tests. Scand. J. Clin. Lab. Invest. 36:1976;805-808.
5. Melnik J., Potter J.L. Variance in capillary and venous glucose levels during a glucose tolerance test. Am. J. Med. Technol. 48(6):1982;543-545.
6. Eriksson K.F., Fex G., Trell E. Capillary-venous differences in blood glucose values during the oral glucose tolerance test. Clin. Chem. 29(5):1983;993.
7. Irjala K., Koskinen P., Näntö V., Peltola O. Interpretation of oral glucose tolerance test: capillary-venous difference in blood glucose and the effect of analytical method. Scand. J. Clin. Lab. Invest. 46:1986;307-313.
8. Vallera D.A., Bissell M.G., Barron W. Accuracy of portable blood glucose monitoring. Effect of glucose level and prandial state. Am. J. Clin. Pathol. 95:1991;247-252.
9. Matthews D.R., Burton S.F., Bown E.et al. Capillary and venous blood glucose measurements using a direct glucose-sensing meter. Diabet. Med. 8:1991;875-880.
10. Qiao Q., Keinänen-Kiukaanniemi S., Rajala U., Uusimäki A., Kivelä S.-L. Random capillary whole blood glucose test as a screening test for diabetes mellitus in a middle-aged population. Scand. J. Clin. Lab. Invest. 55:1995;3-8.
11. Farrer M., Albers C.J., Neil H.A.W., Adams P.C., Laker M.F., Alberti K.G.M.M. Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys. Diabet. Med. 12:1995;325-329.
12. Kuwa K., Nakayama T., Hoshino T., Tominga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin. Chim. Acta. 307:2001;187-192.
13. Neely R.D.G., Kiwanuka J.B., Hadden D.R. Influence of sample type on the interpretation of the oral glucose tolerance test for gestational diabetes mellitus. Diabet. Med. 8:1990;129-134.
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1997;1183-1197.
15. Larsson H., Berglund G., Lindgärde F., Ahrén B. Comparison of ADA and WHO criteria for the diagnosis of diabetes and glucose intolerance. Diabetologia. 41:1998;1124-1125.
16. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ. 317:1998;371-375.
17. Shaw J.E., McCarty D., Zimmet P.Z., De Courten M. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care. 23(Suppl. 2):2000;B5-B10.
18. De Vegt F., Nijpels G., Dekker J.M., Bouter L.M., Stehouwer C.D.A., Heine R.J. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance. Diabetes Care. 21:1998;1686-1690.
19. Bland J.M., Altman D.G. Measurement error proportional to the mean. BMJ. 313:1996;106.
20. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;307-310.
21. Fleiss J.L. Statistical Methods for Rates and Proportions. 1981;Wiley, New York.
22. DeFronzo R.A. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
23. West K.M. Epidemiology of Diabetes and Its Vascular Lesions. 1978;67-68 Elsevier, New York.
24. Tuomilehto J., Lindström J., Eriksson J.G.et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:2001;1343-1350.
25. Knowler W.C., Barrett-Connor E., Fowler S.et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:2002;393-403.
26. Chiasson J., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 359:2002;2072-2077.
27. Scheen A.J. Info-congress. Prevention of type 2 diabetes in obese patients: first results with orlistat in the XENDOS study. Rev. Med. Liege. 57(9):2002;617-621.
28. Fujimoto W.Y. Background and recruitment data for the U.S. Diabetes Prevention Program. Diabetes Care. 23(Suppl. 2):2000;B11-B13.
29. Mensink M., Feskens E.J.M., Saris W.H.M., de Bruin T.W.A., Blaak E.E. Study on lifestyle intervention and impaired glucose tolerance Maastricht (SLIM): preliminary results after one year. Int. J. Obes. 27:2003;377-384.